HOME >> BIOLOGY >> NEWS
Combat Has Little Influence On Health Problems In Vietnam Vets

d the investigators to separate inherited factors from the influences of growing up in the same household environment.

Surveying identical and fraternal twins allowed the investigators to weigh the genetic and environmental factors that make up the mix of influences related to particular health problems. And because of the sample size, the odds are good that those influences will be true for all Vietnam veterans, not just the twins surveyed for this study.

Less than 9 percent of the Vietnam veterans suffered from hypertension, for example, but for identical twins, the odds were greater than 50 percent that if one twin had high blood pressure, so did his brother. Among fraternal twins, the overall rate of hypertension was 9.5 percent, and if one brother had it, his twin had a 34 chance percent of having it as well. Since the primary difference between pairs of identical and fraternal twins is the extent to which they share genes, this result suggests that inherited factors partially explain the development of hypertension.

Overall, the investigators found that, for the entire group of twins, inherited factors explained about 54 percent of the report of hypertension, while combat exposure explained less than one percent. For joint disorders such as arthritis, genetics accounted for 37 percent while combat exposure explained only 2.6 percent.

In all, combat experiences explained no more than 10 percent of the health problems reported by veterans. By contrast, Eisen and colleagues found that inherited factors and environmental experiences other than combat were much more important in determining whether health problems developed.

The researchers gathered data from the twins either by mail or telephone, using a 30-page questionnaire. When the original survey was conducted in 1987, the mean age of the twins/veterans interviewed was 38, and the average participant had been inducted into the service 19 years earlier.


'"/>

Contact: Jim Dryden
dryden@medicine.wustl.edu
(314) 286-0110
Washington University School of Medicine
23-Sep-1998


Page: 1 2 3 4

Related biology news :

1. Method May Be Key In Combating Diarrhea In Animals And Children
2. A Protein Switch May Turn On Heart Cells To Combat Heart Disease
3. Patented Bait System May Hold Answer To Combating Formosan Termites
4. Cold Virus With P53 Gene Tested To Combat Ovarian Cancer
5. Antioxidant Treatment Holds Promise For Combating Malnourishment
6. Local Approaches To Combating Antibiotic Resistance Are Doomed To Failure
7. Plant Pathologists Collaborate Worldwide To Combat Sorghum Ergot
8. Careful Honeybee Breeding Combats Tracheal Mite Pests
9. Discovery Of Genetic Pathways May Provide New Ways To Combat Candida Infections
10. Little-studied waves in the heart may be cause of defibrillation failure
11. Prescott Prize to Diane and Mark Littler

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Combat Has Little Influence Health Problems Vietnam Vets

(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/20/2015)... -- Huntington Memorial Hospital is the first facility in ... wireless monitoring sensor to manage heart failure (HF). The ... heart failure monitoring device that has been proven to ... manage heart failure. The CardioMEMS HF System ... artery (PA) during a non-surgical procedure to directly measure ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
(Date:5/27/2015)... The ALS Therapy Development Institute announced ... Anelixis Therapeutics , $1.5 million toward the development ... innate immune system. The funding comes from the $4 ... 2014 social media phenomenon known as the “ALS Ice ... directly by the Institute through last year’s Ice Bucket ...
(Date:5/27/2015)... SOUTH SAN FRANCISCO, Calif. , May 27, ... therapeutics for the treatment of cancer, today announced ... chief financial officer and Cynthia Ladd ... to joining CytomX, Goeltz was chief financial officer ... previously served as an independent consultant and legal ...
(Date:5/27/2015)... Calif. , May 27, 2015  Two years ... biotech professionals, hackers and citizen scientists, Oakland ... $30,000 crowdfunding campaign promoting its mission to democratize science ... Temescal District. ... Based out of ...
(Date:5/27/2015)... YORK , May 27, 2015  US-Australian drug discovery ... ), announced today that it will present at the Brain ... York on May 29, 2015. The venue is ... Manhattan . The Brain Tumor ... companies, the pharmaceutical industry and the investment community to promote ...
Breaking Biology Technology:Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 2East Bay's Counter Culture Labs Seeks to Open Doors of Science to Public 3Novogen to Present at Brain Tumor Biotech Summit 2015 2Novogen to Present at Brain Tumor Biotech Summit 2015 3Novogen to Present at Brain Tumor Biotech Summit 2015 4Novogen to Present at Brain Tumor Biotech Summit 2015 5
Cached News: